Stocks TelegraphStocks Telegraph
Screener NEW

CNTB Stock Price History and Quote Analysis Insights for Investors

NASDAQ : CNTB

Connect Biopharma Holdings Limited

$1.12
0.03+2.75%
At Close 4:00 PM
61.88
BESG ScoreESG Rating
Loading...

Stock Price Today

Connect Biopharma Holdings Limited (CNTB) stock surged +2.75%, trading at $1.12 on NASDAQ, up from the previous close of $1.09. The stock opened at $1.12, fluctuating between $1.04 and $1.14 in the recent session.

Stock Snapshot

1.09
Prev. Close
1.12
Open
61.88M
Market Cap
55.25M
Number of Shares
1.04
Day Low
1.1441
Day High
-2.87
P/E Ratio
96.38%
Free Float in %
-0.39
EPS (TTM)
1834.41
Book Value
-570.18
Cash Flow per Share
33.72K
Volume

Stock Price History Chart

DateOpenHighLowCloseVolume
Dec 09, 20241.121.151.041.1233.72K
Dec 06, 20241.041.141.011.0841.5K
Dec 05, 20241.141.141.001.00110.33K
Dec 04, 20241.101.151.051.1219.23K
Dec 03, 20241.071.120.981.1137.12K
Dec 02, 20241.021.091.021.0829.31K
Nov 29, 20240.991.080.991.0613.52K
Nov 27, 20240.981.050.941.0339.2K
Nov 26, 20240.971.010.920.9749.84K
Nov 25, 20240.960.990.960.9822.1K
Nov 22, 20241.041.040.991.007.82K
Nov 21, 20240.951.050.950.9914.11K
Nov 20, 20240.921.050.911.0512.74K
Nov 19, 20241.021.020.950.9827.44K
Nov 18, 20241.111.110.981.0121.36K
Nov 15, 20241.051.110.981.1134.1K
Nov 14, 20241.011.010.980.9917.6K
Nov 13, 20241.031.091.001.0022.84K
Nov 12, 20241.081.081.011.0415.92K
Nov 11, 20241.161.160.991.0531.5K

Contact Details

Taicang, 215400

China

Website: https://www.connectbiopharm.comContact: 865 125 3577866

About Company

Connect Biopharma Holdings Limited, a clinical-stage biopharmaceutical company, focuses on the discovery and development of immune modulators for the treatment of serious autoimmune diseases and inflammation. The company's lead product candidate is CBP-201, an anti-interleukin-4 receptor alpha antibody, which is in Phase IIb clinical trial for the treatment of inflammatory allergic diseases, such as atopic dermatitis, asthma, and chronic rhinosinusitis with nasal polyps. Its products also comprise CBP-307, a small molecule modulator of sphingosine 1-phosphate receptor 1, a regulator of T cell mobilization out of lymph nodes into the periphery that is in Phase II for the treatment of autoimmune-related inflammation diseases; CBP-174, a small molecule histamine receptor 3 antagonist for oral administration, which is in a preclinical stage to treat chronic itch associated with skin inflammation; and CBP-233, a preclinical stage humanized antibody against interleukin-33, a cytokine involved in T helper 2 inflammation. The company was founded in 2012 and is headquartered in Taicang, China.

Company Information

Employees81
Beta-0.31
Sales or Revenue$0.00
5Y Sales Change%0%
Fiscal Year EndsDecember
SectorHealthcare
IndustryBiotechnology

Frequently Asked Questions

What is the current Connect Biopharma Holdings Limited (CNTB) stock price?

Connect Biopharma Holdings Limited (NASDAQ: CNTB) stock price is $1.12 in the last trading session. During the trading session, CNTB stock reached the peak price of $1.14 while $1.04 was the lowest point it dropped to. The percentage change in CNTB stock occurred in the recent session was 2.75% while the dollar amount for the price change in CNTB stock was $0.03.

CNTB's industry and sector of operation?

The NASDAQ listed CNTB is part of Biotechnology industry that operates in the broader Healthcare sector. Connect Biopharma Holdings Limited designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.

Who are the executives of CNTB?

Mr. Steven Chan
Chief Financial Officer
Dr. Chin Lee M.D., M.P.H.
Chief Medical Officer
Mr. Jiang Bian J.D.
Gen. Counsel & Chief Compliance Officer
Dr. Wubin Pan M.B.A., Ph.D.
Co-Founder, Pres & Chairman of Directors
Dr. Raul Collazo Ph.D.
Vice President & Global Head of Medical Affairs
Dr. Lei Sun Ph.D.
Vice President of Biologics & Head of CMC
Dr. Malinda V. Longphre Ph.D.
Vice President & Head of US Clinical Operations
Dr. Zheng Wei Ph.D.
Co-Founder, Chief Executive Officer & Director

How CNTB did perform over past 52-week?

CNTB's closing price is 65.19% higher than its 52-week low of $0.68 where as its distance from 52-week high of $2.66 is -57.9%.

How many employees does CNTB have?

Number of CNTB employees currently stands at 81.

Link for CNTB official website?

Official Website of CNTB is: https://www.connectbiopharm.com

How do I contact CNTB?

CNTB could be contacted at phone 865 125 3577866 and can also be accessed through its website. CNTB operates from East R&D Building, Taicang, 215400, China.

How many shares of CNTB are traded daily?

CNTB stock volume for the day was 33.72K shares. The average number of CNTB shares traded daily for last 3 months was 26.35K.

What is the market cap of CNTB currently?

The market value of CNTB currently stands at $61.88M with its latest stock price at $1.12 and 55.25M of its shares outstanding.

logo

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

© 2024 Stocks Telegraph All rights reserved.
Most stock quote data provided by financialmodelingprep.com

stockstelegraph

Don't have an account?

stockstelegraph

Don't have an account?

stockstelegraph

Already have an account?

stockstelegraph
Smart Screening Tools for Exceptional Returns
stockstelegraph

For just $1, you can unlock ST Grading’s top-rated stocks that consistently beat the market. Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.

Ready to Win Big?

Try Now for Just $1!
stockstelegraph